Wasatch Advisors Inc Atara Biotherapeutics, Inc. Transaction History

Wasatch Advisors Inc

$19 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.41 - $2.31 $162,499 - $266,222	115,248 Added 1.39%	8,399,229 $12.4 Million
Q2 2023 Aug 07, 2023	SELL	$1.5 - $3.04 $105,510 - $213,833	-70,340 Reduced 0.84%	8,283,981 $13.3 Million
Q1 2023 May 12, 2023	SELL	$2.8 - $5.46 $102,740 - $200,343	-36,693 Reduced 0.44%	8,354,321 $24.2 Million
Q4 2022 Feb 14, 2023	BUY	$2.85 - $5.18 $725,755 - $1.32 Million	254,651 Added 3.13%	8,391,014 $27.5 Million
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $8.58 Million - $26.3 Million	3,009,640 Added 58.7%	8,136,363 $30.8 Million

Q2 2022 Aug 12, 2022	BUY	$4.69 - $9.84 $6.11 Million - $12.8 Million	1,303,135 Added 34.08%	5,126,723 $39.9 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $16.89 $15.2 Million - $30.4 Million	1,798,072 Added 88.77%	3,823,588 $35.5 Million
Q4 2021 Feb 15, 2022	SELL	$14.7 - $19.89 $13 Million - $17.5 Million	-881,995 Reduced 30.34%	2,025,516 $31.9 Million
Q3 2021 Nov 12, 2021	BUY	$11.99 - $17.9 $6.23 Million - $9.29 Million	519,273 Added 21.74%	2,907,511 $52 Million
Q2 2021 Aug 12, 2021	BUY	$12.89 - $16.58 $4.59 Million - $5.91 Million	356,298 Added 17.53%	2,388,238 $37.1 Million
Q1 2021 May 10, 2021	BUY	$14.0 - $20.72 $781,088 - $1.16 Million	55,792 Added 2.82%	2,031,940 $29.2 Million
Q4 2020 Feb 12, 2021	SELL	$12.67 - $26.23 $9.6 Million - $19.9 Million	-757,328 Reduced 27.71%	1,976,148 $38.8 Million
Q3 2020 Nov 10, 2020	BUY	$11.92 - $15.87 $26 Million - $34.6 Million	2,177,176 Added 391.37%	2,733,476 $35.4 Million
Q2 2020 Aug 12, 2020	BUY	$7.53 - $14.93 $3.14 Million - $6.22 Million	416,549 Added 298.07%	556,300 $8.11 Million
Q1 2020 May 08, 2020	SELL	$5.69 - $17.78 $5.47 Million - $17.1 Million	-961,352 Reduced 87.31%	139,751 $1.19 Million
Q4 2019 Feb 13, 2020	BUY	$10.89 - $16.79 $4.62 Million - $7.12 Million	424,292 Added 62.69%	1,101,103 $18.1 Million
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $858,617 - $1.42 Million	71,373 Added 11.79%	676,811 $9.56 Million
Q2 2019 Aug 07, 2019	BUY	$19.05 - $41.04 $3.4 Million - $7.33 Million	178,632 Added 41.85%	605,438 $0
Q1 2019 May 08, 2019	BUY	$28.4 - $41.74 $2.18 Million - $3.2 Million	76,642 Added 21.89%	426,806 $0
Q4 2018 Feb 14, 2019	BUY	$30.9 - $42.97 $10.4 Million - $14.4 Million	335,900 Added 2354.88%	350,164 $12.2 Million
Q3 2018 Nov 07, 2018	SELL	$35.05 - $43.5 $44,478 - $55,201	-1,269 Reduced 8.17%	14,264 $0
Q2 2018 Aug 02, 2018	BUY	$35.15 - $51.45 $189,599 - $277,521	5,394 Added 53.2%	15,533 $0
Q1 2018 May 02, 2018	BUY	$18.0 - $48.35 $182,502 - $490,220	10,139 New	10,139 $0

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Account